Cargando…
Immunological barriers to haematopoietic stem cell gene therapy
Cell and gene therapies using haematopoietic stem cells (HSCs) epitomize the transformative potential of regenerative medicine. Recent clinical successes for gene therapies involving autologous HSC transplantation (HSCT) demonstrate the potential of genetic engineering in this stem cell type for cur...
Autores principales: | Charlesworth, Carsten T., Hsu, Ian, Wilkinson, Adam C., Nakauchi, Hiromitsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929255/ https://www.ncbi.nlm.nih.gov/pubmed/35301483 http://dx.doi.org/10.1038/s41577-022-00698-0 |
Ejemplares similares
-
In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation
por: Bozhilov, Yavor K., et al.
Publicado: (2023) -
Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice
por: Wilkinson, Adam C., et al.
Publicado: (2021) -
An optimized Sendai viral vector platform for reprogramming to naive pluripotency
por: Charlesworth, Carsten T., et al.
Publicado: (2022) -
Immune ablation and stem-cell therapy in autoimmune disease: Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation
por: van Laar, Jacob M
Publicado: (2000) -
Hoxb5 marks long-term haematopoietic stem cells revealing a homogenous perivascular niche
por: Chen, James Y., et al.
Publicado: (2016)